CBER: Proper Biologic Application Format May Speed Review

Biologics makers may accelerate FDA reviews if they submit documents in the correct binding and format detailed in new standard operating procedures and policies (SOPP) for CBER staff. In its first written SOPP detailing regulatory document submission requirements, CBER says documents that arrive in the correct binding could be more rapidly processed and routed for review.
Drug Industry Daily